BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38567146)

  • 1. Interstitial needles versus intracavitary applicators only for locally advanced cervical cancer: results from real-life dosimetric comparisons.
    Cordoba A; Gesta E; Escande A; Noeuveglise A; Cayez R; Halty A; Ladjimi MT; Narducci F; Hudry D; Martinez Gomez C; Cordoba S; Le Deley MC; Barthoulot M; Lartigau EF
    Front Oncol; 2024; 14():1347727. PubMed ID: 38567146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcome of combined intracavitary / interstitial brachytherapy using a hybrid applicator in locally advanced cervical cancer.
    Rogowski P; Rottler M; Walter F; Saicic S; Niyazi M; Well J; Nierer L; Trillsch F; Burges A; Mahner S; Belka C; Corradini S
    Gynecol Oncol; 2022 Sep; 166(3):576-581. PubMed ID: 35764443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Outcomes of MRI-Guided Adaptive Brachytherapy for Each Fraction in Locally Advanced Cervical Cancer: A Single Institution Experience.
    Chi Y; Pan Y; Zhang N; Han D; Guo X; Mao Z; Cheng G
    Front Oncol; 2022; 12():841980. PubMed ID: 35372065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of combined intracavitary/interstitial brachytherapy including oblique needles in locally advanced cervix cancer.
    Serban M; Fokdal L; Nielsen SK; Hokland SB; Hansen AT; Spejlborg H; Rylander S; Petric P; Lindegaard JC; Tanderup K
    Brachytherapy; 2021; 20(4):796-806. PubMed ID: 33994344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical use of the Utrecht applicator for combined intracavitary/interstitial brachytherapy treatment in locally advanced cervical cancer.
    Nomden CN; de Leeuw AA; Moerland MA; Roesink JM; Tersteeg RJ; Jürgenliemk-Schulz IM
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1424-30. PubMed ID: 21669505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Boost modalities in cervical cancer: dosimetric comparison between intracavitary BT vs. intracavitary + interstitial BT vs. SBRT.
    Benkhaled S; Diakité K; Jullian N; Poeta S; Vandekerkhove C; Van Houtte P; Van Gestel D; De Caluwé A
    Radiat Oncol; 2023 Jun; 18(1):105. PubMed ID: 37381016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of single insertion accelerated MR-image guided brachytherapy following chemo-radiation in locally advanced cervix cancer: modifying our EMBRACE during the COVID pandemic.
    Stevens MJ; Ko F; Martland J; Brown R; Bell L; Atyeo J; Yim J
    Radiat Oncol; 2023 Mar; 18(1):54. PubMed ID: 36941643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Image-guided adaptive brachytherapy for advanced cervical cancer spreading to the bladder and/or rectum: Clinical outcome and prognostic factors.
    Ka K; Laville A; Rassy E; Ayachi RE; Pautier P; Ba MB; Bockel S; Achkar S; Espenel S; Maulard A; Morice P; Gouy S; Haie-Meder C; Sun R; Chargari C
    Gynecol Oncol; 2023 Jan; 168():32-38. PubMed ID: 36370612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can combined intracavitary/interstitial approach be an alternative to interstitial brachytherapy with the Martinez Universal Perineal Interstitial Template (MUPIT) in computed tomography-guided adaptive brachytherapy for bulky and/or irregularly shaped gynecological tumors?
    Oike T; Ohno T; Noda SE; Kiyohara H; Ando K; Shibuya K; Tamaki T; Takakusagi Y; Sato H; Nakano T
    Radiat Oncol; 2014 Oct; 9():222. PubMed ID: 25319341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI-guided adaptive brachytherapy for locally advanced cervix cancer: Treatment outcomes from a single institution in Hong Kong.
    Wu PY; Wong TPW; Yip YYC; Chang TYA; Chan LKL; Lee MCH; Law LYA; Yeung MWR; Soong SI
    Brachytherapy; 2019; 18(2):171-179. PubMed ID: 30581053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ring Versus Ovoids and Intracavitary Versus Intracavitary-Interstitial Applicators in Cervical Cancer Brachytherapy: Results From the EMBRACE I Study.
    Serban M; Kirisits C; de Leeuw A; Pötter R; Jürgenliemk-Schulz I; Nesvacil N; Swamidas J; Hudej R; Lowe G; Hellebust TP; Menon G; Oinam A; Bownes P; Oosterveld B; De Brabandere M; Koedooder K; Langeland Marthinsen AB; Whitney D; Lindegaard J; Tanderup K;
    Int J Radiat Oncol Biol Phys; 2020 Apr; 106(5):1052-1062. PubMed ID: 32007365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes of adaptive intracavitary and interstitial brachytherapy technique in locally advanced cervical cancer: A real-world data.
    Kashid SR; Gurram L; Pullan S; Chopra S; Mittal P; Ghadi Y; Dheera A; Scaria L; Kohle S; Kadam S; Ghosh J; Rath S; Gupta S; Mahantshetty U
    Brachytherapy; 2024 Apr; ():. PubMed ID: 38641455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parametrial boosting in locally advanced cervical cancer: combined intracavitary/interstitial brachytherapy vs. intracavitary brachytherapy plus external beam radiotherapy.
    Mohamed S; Kallehauge J; Fokdal L; Lindegaard JC; Tanderup K
    Brachytherapy; 2015; 14(1):23-8. PubMed ID: 25455382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computed Tomography-Guided Interstitial Brachytherapy for Locally Advanced Cervical Cancer: Introduction of the Technique and a Comparison of Dosimetry With Conventional Intracavitary Brachytherapy.
    Liu ZS; Guo J; Zhao YZ; Lin X; Zhang BY; Zhang C; Wang HY; Yu L; Ren XJ; Wang TJ
    Int J Gynecol Cancer; 2017 May; 27(4):768-775. PubMed ID: 28267131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracavitary/Interstitial Applicator Plus Distal Parametrial Free Needle Interstitial Brachytherapy in Locally Advanced Cervical Cancer: A Dosimetric Study.
    Qu HD; Han DM; Zhang N; Mao Z; Cheng GH
    Front Oncol; 2020; 10():621347. PubMed ID: 33680943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practical needle selection for Vienna-style applicators: improving therapeutic ratio in hybrid intracavitary-interstitial brachytherapy.
    Martin DA; Taunk NK; Anamalayil S; Mangal V; Marcel J; Hubley E
    J Contemp Brachytherapy; 2021 Oct; 13(5):533-540. PubMed ID: 34759978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes and comparison of dosimetric parameters between intracavitary (Fletcher) and combined intracavitary/interstitial (Utrecht) brachytherapy in locally advanced cervical cancer.
    Sarwar KA; Hussain S; Syed AS; Khan K; Maqsood T; Azeem T
    Brachytherapy; 2024; 23(1):10-17. PubMed ID: 37813708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy and toxicity of radio-chemotherapy and magnetic resonance imaging-guided brachytherapy for locally advanced cervical cancer patients: A mono-institutional experience.
    Lakosi F; de Cuypere M; Viet Nguyen P; Jansen N; Warlimont B; Gulyban A; Gennigens C; Seidel L; Delbecque K; Coucke P; Hermesse J; Kridelka F
    Acta Oncol; 2015; 54(9):1558-66. PubMed ID: 26406152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of dosimetric parameters in the treatment planning of magnetic resonance imaging-based intracavitary image-guided adaptive brachytherapy with and without optimization using the central shielding technique.
    Nishikawa R; Yoshida K; Ebina Y; Omoteda M; Miyawaki D; Ishihara T; Ejima Y; Akasaka H; Satoh H; Kyotani K; Takahashi S; Sasaki R
    J Radiat Res; 2018 May; 59(3):316-326. PubMed ID: 29518234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI-guided treatment-planning optimisation in intracavitary or combined intracavitary/interstitial PDR brachytherapy using tandem ovoid applicators in locally advanced cervical cancer.
    Jürgenliemk-Schulz IM; Tersteeg RJ; Roesink JM; Bijmolt S; Nomden CN; Moerland MA; de Leeuw AA
    Radiother Oncol; 2009 Nov; 93(2):322-30. PubMed ID: 19748695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.